These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20200247)

  • 1. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.
    Gottwein JM; Scheel TK; Callendret B; Li YP; Eccleston HB; Engle RE; Govindarajan S; Satterfield W; Purcell RH; Walker CM; Bukh J
    J Virol; 2010 May; 84(10):5277-93. PubMed ID: 20200247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
    Li YP; Ramirez S; Mikkelsen L; Bukh J
    J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.
    Sakai A; Takikawa S; Thimme R; Meunier JC; Spangenberg HC; Govindarajan S; Farci P; Emerson SU; Chisari FV; Purcell RH; Bukh J
    J Virol; 2007 Jul; 81(13):7208-19. PubMed ID: 17409145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
    Vigón L; Vázquez-Morón S; Berenguer J; González-García J; Jiménez-Sousa MÁ; Guardiola JM; Crespo M; de Los Santos I; Von Wichmann MA; Carrero A; Yélamos MB; Gómez J; Resino S; Martínez I;
    Sci Rep; 2019 Aug; 9(1):12163. PubMed ID: 31434968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
    Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
    J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.
    Yanagi M; St Claire M; Shapiro M; Emerson SU; Purcell RH; Bukh J
    Virology; 1998 Apr; 244(1):161-72. PubMed ID: 9581788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
    Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a.
    Bukh J; Apgar CL; Govindarajan S; Emerson SU; Purcell RH
    J Viral Hepat; 2001 May; 8(3):228-31. PubMed ID: 11380802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence.
    Lanford RE; Lee H; Chavez D; Guerra B; Brasky KM
    J Gen Virol; 2001 Jun; 82(Pt 6):1291-1297. PubMed ID: 11369872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.
    Yanagi M; Purcell RH; Emerson SU; Bukh J
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8738-43. PubMed ID: 9238047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.
    Yanagi M; Purcell RH; Emerson SU; Bukh J
    Virology; 1999 Sep; 262(1):250-63. PubMed ID: 10489358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.
    Carlsen TH; Pedersen J; Prentoe JC; Giang E; Keck ZY; Mikkelsen LS; Law M; Foung SK; Bukh J
    Hepatology; 2014 Nov; 60(5):1551-62. PubMed ID: 25043937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.
    Gottwein JM; Scheel TK; Jensen TB; Ghanem L; Bukh J
    Gastroenterology; 2011 Sep; 141(3):1067-79. PubMed ID: 21699793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
    Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.
    Bukh J; Thimme R; Meunier JC; Faulk K; Spangenberg HC; Chang KM; Satterfield W; Chisari FV; Purcell RH
    J Virol; 2008 Aug; 82(16):8183-95. PubMed ID: 18550671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
    Kato T; Choi Y; Elmowalid G; Sapp RK; Barth H; Furusaka A; Mishiro S; Wakita T; Krawczynski K; Liang TJ
    Hepatology; 2008 Sep; 48(3):732-40. PubMed ID: 18712792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses.
    Gottwein JM; Jensen SB; Li YP; Ghanem L; Scheel TK; Serre SB; Mikkelsen L; Bukh J
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1291-303. PubMed ID: 23274664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.
    Prentoe J; Serre SB; Ramirez S; Nicosia A; Gottwein JM; Bukh J
    J Virol; 2014 Feb; 88(3):1725-39. PubMed ID: 24257605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.